0001127602-21-002862.txt : 20210128
0001127602-21-002862.hdr.sgml : 20210128
20210128172751
ACCESSION NUMBER: 0001127602-21-002862
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210127
FILED AS OF DATE: 20210128
DATE AS OF CHANGE: 20210128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lucchino David L.
CENTRAL INDEX KEY: 0001785288
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 21566545
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY, SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY, SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-01-27
0001703647
Frequency Therapeutics, Inc.
FREQ
0001785288
Lucchino David L.
C/O FREQUENCY THERAPEUTICS, INC.
19 PRESIDENTIAL WAY, 2ND FLOOR
WOBURN
MA
01801
1
1
President and CEO
Common Stock
2021-01-27
4
M
0
9196
.61
A
317282
D
Common Stock
2021-01-27
4
S
0
9196
42.50
D
308086
D
Stock Option
.61
2021-01-27
4
M
0
9196
0
D
2028-05-21
Common Stock
9196
237651
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020.
The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022.
/s/ Michael D. Bookman, Attorney-in-Fact for David L. Lucchino
2021-01-28